Official start of project LEGATO

The European Organisation for Research and Treatment of Cancer (EORTC) and the Syreon Research Institute are delighted to announce the official start of LEGATO, a pragmatic phase III clinical trial focusing on recurrent Glioblastoma. This is the first official trial looking into the potential benefits of chemo-irradiation compared to chemotherapy alone to improve disease control […]

Three new EORTC clinical trials funded by the EU

Brussels, April 24, 2023 – The European Commission has approved the funding of three new research projects coordinated by EORTC. Thanks to these grants, EORTC will perform three innovative pragmatic clinical trials optimising treatments for patients with refractory cancers starting summer of 2023. Public funding is essential to address clinically relevant questions with no commercial interest […]